Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 31.82B | 29.51B | 28.68B | 29.18B | 23.11B | 26.16B |
Gross Profit | 8.60B | 7.60B | 7.04B | 7.13B | 5.52B | 6.77B |
EBITDA | 3.09B | 2.83B | 4.18B | 3.62B | 2.17B | 2.14B |
Net Income | 968.72M | 785.63M | 1.37B | 1.32B | 651.31M | 624.83M |
Balance Sheet | ||||||
Total Assets | 44.67B | 43.25B | 40.80B | 40.53B | 36.07B | 35.74B |
Cash, Cash Equivalents and Short-Term Investments | 6.39B | 6.21B | 5.09B | 6.11B | 5.36B | 4.12B |
Total Debt | 7.46B | 6.76B | 6.08B | 5.88B | 6.13B | 6.71B |
Total Liabilities | 18.14B | 17.42B | 16.40B | 18.93B | 17.16B | 17.54B |
Stockholders Equity | 22.86B | 22.28B | 21.45B | 19.49B | 17.33B | 16.71B |
Cash Flow | ||||||
Free Cash Flow | 202.31M | 1.34B | -1.44B | 651.23M | 1.92B | 1.15B |
Operating Cash Flow | 2.21B | 3.23B | 162.21M | 1.63B | 3.02B | 2.45B |
Investing Cash Flow | -1.78B | -1.53B | -1.10B | -366.57M | -629.78M | -1.63B |
Financing Cash Flow | -275.73M | -535.51M | -399.08M | -732.64M | -998.76M | -597.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.40B | 9.74 | 2.20% | 2.63% | 268.28% | ||
80 Outperform | ¥11.47B | 9.34 | 3.18% | 0.94% | 3.26% | ||
80 Outperform | ¥17.00B | 9.70 | 2.10% | 20.91% | 18.64% | ||
75 Outperform | ¥11.21B | 8.38 | 5.49% | 13.50% | 63.21% | ||
65 Neutral | $10.85B | 15.47 | 5.22% | 1.89% | 3.09% | -26.84% | |
51 Neutral | ¥5.28B | ― | 1.82% | 10.20% | -142.32% |